CF recognised as a top Middle East consulting firm by Consultancy-me
We are thrilled to announce that CF has been [...]
What does the 2024 Budget mean for the NHS and Life Sciences?
Today sees the release of the 2024 Budget – [...]
Maximising healthcare outcomes through NHS-industry partnerships
NHS-industry partnerships aim to develop and implement projects that [...]
Review into the operational effectiveness of the CQC
In May 2024, Dr Penny Dash conducted a review [...]
Partnering for progress: a data-driven analysis of NHS-industry partnerships
Early evidence links NHS-industry partnerships with improved prescribing practices [...]
The greatest challenges and opportunities in dementia
Dementia is one of the UK's most pressing health [...]
The growing impact of dementia and the importance of early diagnosis
Dementia is now the leading cause of death in [...]
Investing in the Dementia Age
Dementia is the UK’s number one killer and the [...]
Improving market access of medicines in the UK – Our view in 2024
Addressing access and adoption of medicines in the UK [...]
FDA Guidance: Using EHRs and Medical Claims Data to support drug and biological products regulation
The FDA has published guidance as part of its [...]
